Track the 대화제약 stock price and the full insider trade history of the company, a listed equity based in South Korea. Shares are listed on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 대화제약 has recorded 132 insider filings. Market capitalisation: €182.4bn. The latest transaction was disclosed on 2 July 2026 (Mixed). Among the most active insiders: 김수지. All data is openly available.
129
Insider Decl.
n/a
Thresholds
€69,224
17 ops.
Buy Volume
€29,868
34 ops.
Sell Volume
31Σ signal
Buys €69,224€29,868 Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 21,721 of 29,063 companies
34.7
score / 100
Value
34
Quality
35
FCF yld0.3%
Earn yld0.8%
EV/EBITDA18.8x
ROE6.1%
Gross mgn33%
Net mgn1.2%
Debt/EBITDA6.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
대화제약 es una empresa que opera en el sector de la salud y farmacéutico, cotiza en el mercado XKRX. Se centra en el desarrollo y la distribución de productos farmacéuticos.